High-risk smoldering myeloma score using M-protein, free light chain ratio, and marrow plasma cells.
Waiting For Required Inputs
Complete the required fields to generate the oncology interpretation.
Guidelines & Evidence
Clinical Details
Section 1
When to Use
Primary Use
High-risk smoldering myeloma score using M-protein, free light chain ratio, and marrow plasma cells.
Section 2
Formula & Logic
Clinical Inputs
M-protein
g/dL
Involved/uninvolved FLC ratio
Numeric entry
Bone marrow plasma cells
%
Section 3
Pearls/Pitfalls
Result Bands
Section 4
Next Steps
Suggested Next Steps
01
Interpret the result in the full disease-specific clinical context.
02
Correlate with pathology, imaging, performance status, and multidisciplinary guidance.
Section 5
Evidence Appraisal
Evidence Base
High-risk smoldering myeloma score using M-protein, free light chain ratio, and marrow plasma cells.
OpiCalc Medical Oncology Module • Myeloma & MPN. 2026;Logic implemented from widely used contemporary oncology classification, prognostic, and response-assessment frameworks.
Section 6
Literature
Context
Mayo 20/2/20 (SMM) is included in the oncology module as a structured decision-support tool for myeloma & mpn workflows.
